Shamburg News · 8-K filed Nov 18, 2026, 10:06 AM EST
Impact BioMedical Completes Business Combination with Dr Ashleys Limited; Shares Delisted from NYSE American
IBO · IMPACT BIOMEDICAL INC.
- Acquisition
- Delisting
- Leadership change
- Other event
- Materiality: high
On November 17, 2026, Impact BioMedical Inc. completed its merger with Merger Sub and a share exchange with PubCo and the Zoar Shareholder, making the company a wholly-owned subsidiary of PubCo. Company common stock was converted into 8,640,000 PubCo ordinary shares, representing approximately 4.80% of PubCo's outstanding shares at closing, following a 1-for-12.62 reverse split. The company requested NYSE American suspend trading and withdraw its listing, and it intends to file Form 15 to deregister its common stock; the board and CFO/COO resigned and new PubCo directors and officers were appointed.
Source: SEC EDGAR, Form 8-K, Items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, accession 0001493152-26-053017.
Written from the filing by Shamburg Markets. Figures are as reported by the company.